Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 7337
TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190265(US9175357, 5827)
Affinity DataIC50: 8.60E+3nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190264(US9175357, 5826)
Affinity DataIC50: 1.08E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190261(US9175357, 5788)
Affinity DataIC50: 1.65E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190266(US9175357, 5830)
Affinity DataIC50: 1.65E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190262(US9175357, 5791)
Affinity DataIC50: 1.85E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190259(US9175357, 5785)
Affinity DataIC50: 2.95E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190263(US9175357, 5792)
Affinity DataIC50: 3.12E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190260(US9175357, 5786)
Affinity DataIC50: 6.47E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190258(US9175357, 5756)
Affinity DataIC50: 9.90E+4nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190256(US9175357, 5753)
Affinity DataIC50: 1.04E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190257(US9175357, 5754)
Affinity DataIC50: 1.25E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190253(US9175357, 5603)
Affinity DataIC50: 2.50E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190254(US9175357, 5604)
Affinity DataIC50: 3.00E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190249(US9175357, 5598)
Affinity DataIC50: 3.20E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190246(US9175357, 5594)
Affinity DataIC50: 3.50E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190244(US9175357, 5591)
Affinity DataIC50: 3.75E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190245(US9175357, 5593)
Affinity DataIC50: 3.80E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190252(US9175357, 5601)
Affinity DataIC50: 4.00E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190247(US9175357, 5595)
Affinity DataIC50: 4.75E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190248(US9175357, 5597)
Affinity DataIC50: 5.00E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190251(US9175357, 5600)
Affinity DataIC50: 5.50E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190255(US9175357, 5607)
Affinity DataIC50: 6.00E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
University of South Carolina

US Patent
LigandPNGBDBM190250(US9175357, 5599)
Affinity DataIC50: 6.00E+5nMpH: 8.0 T: 2°CAssay Description:The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
Go to US Patent